|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Oxford Immunotec, Inc.
| | | Phone: | (508) 481-4648 | Fax: | (508) 481-4672 | Year Established: | 2002 | Ticker: | OXFD | Exchange: | NASDAQ | Main Contact: | Jeff Schroeder, CCO | | Other Contacts: | Richard Wenstrup, MD, CMO Stefan Linn, COO Elizabeth M. Keiley, VP & General Counsel Richard Altieri, CFO Peter Wrighton-Smith Ph.D., CEO Karen Koski, Head of Strategy and Investor Relations
| | Company Description | Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. The Company's first product is the T-SPOT.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The T-SPOT.CMV test is the Company's second product and the first in a series of products intended for the transplantation market. Overall, the Company has seven active development programs, each of which leverages our T cell, B cell and innate immune measuring technology. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass. | |
|
|
|
|
|